-+ 0.00%
-+ 0.00%
-+ 0.00%

On December 8, Fuan Pharmaceutical announced that its subsidiary product, paramivir injection, was newly included in the 2025 “National Medical Insurance Drug Catalogue” to treat influenza A or B.

Zhitongcaijing·12/08/2025 08:01:05
Listen to the news
On December 8, Fuan Pharmaceutical announced that its subsidiary product, paramivir injection, was newly included in the 2025 “National Medical Insurance Drug Catalogue” to treat influenza A or B.